Precipio, Inc. Common Stock Stock Prediction
AI-powered sentiment analysis and prediction trends for PRPO, updated each market day.
PRPO AI Sentiment
AI predicts Precipio, Inc. Common Stock stock is likely to decrease over the next 10 market days.
Prediction date: June 8, 2026
Subscribers see precise scores, buy/sell targets, and full analytics.
About Precipio, Inc. Common Stock
Precipio Inc is a healthcare biotechnology company focused on cancer diagnostics. Its objective is to enhance diagnostic accuracy & accessibility while building a sustainable business model that supports ongoing innovation. The company operates Clinical Laboratory Improvement Amendments laboratories in both New Haven, Connecticut, & Omaha, Nebraska, providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. The company operates in a single segment, which includes two divisions: the Pathology Services Division & the Products Division. The Pathology Services provides specialized cancer diagnostic testing services. The pathology services division specializes in diagnostic testing focused mainly on hematologic cancers.
Sector
Exchange
Market Cap
$41,753,009
Cap Tier
Employees
71
Headquarters
NEW HAVEN, CT
Listed Since
July 18, 2000
Website
PRPO Sentiment Trend — Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
PRPO Volatility
Precipio, Inc. Common Stock has shown high price volatility over the last 5 trading days. High volatility means larger price swings — this can present both opportunity and risk for traders.
